On or around 08/25/2017 (Other)
Filing Date: January 12, 2017
According to the Complaint, it is alleged in violation of the Securities Act, Defendants negligently issued untrue statements of material facts and omitted to state material facts required to be stated from the Registration Statement and incorporated Offering Materials that the Company filed with the SEC in support of the Offering.
Company & Securities Information
Defendant: KemPharm, Inc.
Industry: Biotechnology & Drugs
Headquarters: United States
Ticker Symbol: KMPH
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Kevin Christians, et al. v. KemPharm, Inc., et al.
COURT: S.D. Iowa
DOCKET #: 17-CV-00002
JUDGE: Hon. Robert W. Pratt
DATE FILED: 01/12/2017
CLASS PERIOD START: 04/16/2015
CLASS PERIOD END: 01/12/2017
PLAINTIFF FIRMS NAMED IN COMPLAINT:
DICKINSON MACKAMAN TYLER & HAGEN PC 699 Walnut Street, Suite 1600, DICKINSON MACKAMAN TYLER & HAGEN PC , IA 50309 ·
Scott + Scott LLP (NY) 405 Lexington Avenue, 40th Floor, The Chrysler Building, Scott + Scott LLP (NY), NY 10174 (212) 223-6444 (212) 223-6444 ·